EUVIMEDEUVIMED entdecken
Leserbrief

Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening

Jonathan P Bestwick iD, Nicholas J Wald iD

Journal of Medical Screening · 2026-12 · 33 (4) · 319-319

DOI: 10.1177/09691413261453331 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Medical Screening, online erschienen am 26.05.2026. Verfasst von Jonathan P Bestwick und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Clinical Haematology, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • UCL Institute of Health Informatics, University College London, London, UK.

ORCID-Profile: Jonathan P Bestwick, Nicholas J Wald

Zitieren

APA

Bestwick, J. P., & Wald, N. J. (2026). Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening. Journal of Medical Screening, 33(4), 319-319. https://doi.org/10.1177/09691413261453331

Vancouver

Bestwick JP, Wald NJ. Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening. Journal of Medical Screening. 2026;33(4):319-319. doi:10.1177/09691413261453331

BibTeX
@article{Bestwick2026,
  author = {Bestwick, Jonathan P and Wald, Nicholas J},
  title = {Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening},
  journal = {Journal of Medical Screening},
  year = {2026},
  volume = {33},
  number = {4},
  pages = {319--319},
  doi = {10.1177/09691413261453331}
}
Kostenlos starten →